Review





Similar Products

96
Proteintech antibodies against cd31
Antibodies Against Cd31, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against cd31/product/Proteintech
Average 96 stars, based on 1 article reviews
antibodies against cd31 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

98
R&D Systems antibodies against cd31
Antibodies Against Cd31, supplied by R&D Systems, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against cd31/product/R&D Systems
Average 98 stars, based on 1 article reviews
antibodies against cd31 - by Bioz Stars, 2026-05
98/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology phycoerythrinconjugated antibody against cd31
Phycoerythrinconjugated Antibody Against Cd31, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phycoerythrinconjugated antibody against cd31/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
phycoerythrinconjugated antibody against cd31 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

98
R&D Systems goat polyclonal antibodies against cd31
Goat Polyclonal Antibodies Against Cd31, supplied by R&D Systems, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat polyclonal antibodies against cd31/product/R&D Systems
Average 98 stars, based on 1 article reviews
goat polyclonal antibodies against cd31 - by Bioz Stars, 2026-05
98/100 stars
  Buy from Supplier

96
Proteintech antibody against cd31
Cur-SN inhibited the migration, invasion, apoptosis and senescence of VECs in vitro. VECs were treated with different concentrations of Cur-SN (0, 20, 30, 40µM) ( A ) Representative images of VECs under a light microscope (400×). <t>CD31</t> fluorescence staining (red) and stained for nucler (blue). ( B-1 ) Representative photomicrographs of the wound edge in the scratch assay after 48 h treatment in each group. ( B-2 ) Results of quantitative analysis of cell migration rate. ( C-1 ) Representative images of the transwell migration of VECs was determined by transwell migration assay after 48 h treatment in each group. ( C-2 ) Results of quantitative analysis of VECs transwell migration assay. ( D ) Representative photomicrographs of senescence-β-galactosidase staining was performed and green staining indicated the senescence-β-galactosidase staining positivity. ( E ) Apoptotic rates of different groups were determined using a flow apoptosis kit. Quadrants drawn on histograms allow to define the repartition of VECs populations among apoptotic (Annexin V+/PI+), necrotic (Annexin V-/PI+), pre‐apoptotic (Annexin V+/PI‐), and normal (Annexin V‐/PI‐) cells. ( F ) Representative images and quantitative analysis of BCL2, BAX, Caspase 9, P21, P53, GAPDH in VECs of WB analysis. All data are expressed as mean ± SD, n = 3. * p < 0.05,** p < 0.01 and *** p < 0.001 as compared with the control group
Antibody Against Cd31, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibody against cd31/product/Proteintech
Average 96 stars, based on 1 article reviews
antibody against cd31 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

98
R&D Systems primary antibodies against cd31
Endothelial OTUD1 is significantly upregulated in diabetic wound tissues. (A) Real-time qPCR analysis for mRNA levels of OTU subfamily members in the skin wound tissues from control and T2DM mice (n = 7). (B) Immunoblotting and densitometric quantification analyses illustrating OTUD1 protein expression in skin wound tissues from both control and T2DM mice (n = 3). (C) Representative immunohistochemical images and (D) quantitative analysis of showing OTUD1-positive cells (brown) in the skin wound tissues of mice. Black arrowheads indicate positive OTUD1 signals (Scale bar = 50 μm; n = 7). (E) Immunoblot and quantitative analysis of OTUD1 protein expression in HUVECs, HaCaT, HDFa, and MPM cells (n = 4). (F) Representative immunofluorescence images displaying the colocalization of <t>CD31</t> (red) and OTUD1 (green) in mouse skin wound tissues, with white arrowheads showing OTUD1 and CD31 colocalization sites. Tissues were counterstained with DAPI (blue; Scale bar = 50 μm). (G) Immunofluorescence staining and (H) quantitative analysis of OTUD1-positive cells (red) in both control and HG + PA-treated HUVECs for 4 h, counterstained with DAPI (blue; Scale bar = 50 μm). (I) Time-course study of OTUD1 expression in response to HG + PA in HUVECs, including immunoblot analysis and quantitative measurement (n = 3). Data are shown as mean ± SEM. Statistical analyses were performed using a two-tailed unpaired Student's t -test (A, B, D), Welch’s t test (H), and one-way ANOVA analysis followed by Bonferroni post-hoc test (E, I). HG + PA indicates treatment with 50 mM HG and 300 μM PA, unless specified otherwise. Abbreviations: Ctrl, control; T2DM, type 2 diabetes mellitus; OTU, ovarian tumor protease; HUVECs, human umbilical vein endothelial cells; HaCaT, human keratinocytes; HDFa, human dermal fibroblasts-adult; MPMs, mouse primary peritoneal macrophages; DAPI, 4ʹ,6-diamidino-2-phenylindole; HG + PA, high glucose plus palmitic acid; and OTUD1, ovarian tumor deubiquitinase 1.
Primary Antibodies Against Cd31, supplied by R&D Systems, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against cd31/product/R&D Systems
Average 98 stars, based on 1 article reviews
primary antibodies against cd31 - by Bioz Stars, 2026-05
98/100 stars
  Buy from Supplier

Image Search Results


Cur-SN inhibited the migration, invasion, apoptosis and senescence of VECs in vitro. VECs were treated with different concentrations of Cur-SN (0, 20, 30, 40µM) ( A ) Representative images of VECs under a light microscope (400×). CD31 fluorescence staining (red) and stained for nucler (blue). ( B-1 ) Representative photomicrographs of the wound edge in the scratch assay after 48 h treatment in each group. ( B-2 ) Results of quantitative analysis of cell migration rate. ( C-1 ) Representative images of the transwell migration of VECs was determined by transwell migration assay after 48 h treatment in each group. ( C-2 ) Results of quantitative analysis of VECs transwell migration assay. ( D ) Representative photomicrographs of senescence-β-galactosidase staining was performed and green staining indicated the senescence-β-galactosidase staining positivity. ( E ) Apoptotic rates of different groups were determined using a flow apoptosis kit. Quadrants drawn on histograms allow to define the repartition of VECs populations among apoptotic (Annexin V+/PI+), necrotic (Annexin V-/PI+), pre‐apoptotic (Annexin V+/PI‐), and normal (Annexin V‐/PI‐) cells. ( F ) Representative images and quantitative analysis of BCL2, BAX, Caspase 9, P21, P53, GAPDH in VECs of WB analysis. All data are expressed as mean ± SD, n = 3. * p < 0.05,** p < 0.01 and *** p < 0.001 as compared with the control group

Journal: Journal of Biological Engineering

Article Title: Curcumin-loaded silk fibroin scaffold promotes cartilage regeneration by inhibiting angiogenesis via Drp1/ROS-mediated mitochondrial regulation

doi: 10.1186/s13036-026-00624-1

Figure Lengend Snippet: Cur-SN inhibited the migration, invasion, apoptosis and senescence of VECs in vitro. VECs were treated with different concentrations of Cur-SN (0, 20, 30, 40µM) ( A ) Representative images of VECs under a light microscope (400×). CD31 fluorescence staining (red) and stained for nucler (blue). ( B-1 ) Representative photomicrographs of the wound edge in the scratch assay after 48 h treatment in each group. ( B-2 ) Results of quantitative analysis of cell migration rate. ( C-1 ) Representative images of the transwell migration of VECs was determined by transwell migration assay after 48 h treatment in each group. ( C-2 ) Results of quantitative analysis of VECs transwell migration assay. ( D ) Representative photomicrographs of senescence-β-galactosidase staining was performed and green staining indicated the senescence-β-galactosidase staining positivity. ( E ) Apoptotic rates of different groups were determined using a flow apoptosis kit. Quadrants drawn on histograms allow to define the repartition of VECs populations among apoptotic (Annexin V+/PI+), necrotic (Annexin V-/PI+), pre‐apoptotic (Annexin V+/PI‐), and normal (Annexin V‐/PI‐) cells. ( F ) Representative images and quantitative analysis of BCL2, BAX, Caspase 9, P21, P53, GAPDH in VECs of WB analysis. All data are expressed as mean ± SD, n = 3. * p < 0.05,** p < 0.01 and *** p < 0.001 as compared with the control group

Article Snippet: After permeabilization with 0.5% Triton X-100 and blocking with 5% BSA at room temperature, the sections were incubated overnight at 4 °C with a primary antibody against CD31 (Proteintech, Nanjing; 1:100 dilution).

Techniques: Migration, In Vitro, Light Microscopy, Fluorescence, Staining, Wound Healing Assay, Transwell Migration Assay, Control

Effects of Cur-SN-GM on a rat model the femoral trochlear cartilage defect in vivo. ( A )Images of repairing cartilage injury in knee joint of rats. ( B ) HE staining images ( C ) Toluidine blue staining images. ( D ) collagen-II immumohistochemical staining images. ( E ) Representative fluorescent images of CD31 in synovium of joint. ( F ) relative quantitative analysis of toluidine blue average optical density. ( G ) Collagen type II average optical density (H)CD31 integrated flourescence density. ( I ) ICRS scor. Scale bar = 200 μm, * p < 0.05,** p < 0.01 and *** p < 0.001

Journal: Journal of Biological Engineering

Article Title: Curcumin-loaded silk fibroin scaffold promotes cartilage regeneration by inhibiting angiogenesis via Drp1/ROS-mediated mitochondrial regulation

doi: 10.1186/s13036-026-00624-1

Figure Lengend Snippet: Effects of Cur-SN-GM on a rat model the femoral trochlear cartilage defect in vivo. ( A )Images of repairing cartilage injury in knee joint of rats. ( B ) HE staining images ( C ) Toluidine blue staining images. ( D ) collagen-II immumohistochemical staining images. ( E ) Representative fluorescent images of CD31 in synovium of joint. ( F ) relative quantitative analysis of toluidine blue average optical density. ( G ) Collagen type II average optical density (H)CD31 integrated flourescence density. ( I ) ICRS scor. Scale bar = 200 μm, * p < 0.05,** p < 0.01 and *** p < 0.001

Article Snippet: After permeabilization with 0.5% Triton X-100 and blocking with 5% BSA at room temperature, the sections were incubated overnight at 4 °C with a primary antibody against CD31 (Proteintech, Nanjing; 1:100 dilution).

Techniques: In Vivo, Staining

Endothelial OTUD1 is significantly upregulated in diabetic wound tissues. (A) Real-time qPCR analysis for mRNA levels of OTU subfamily members in the skin wound tissues from control and T2DM mice (n = 7). (B) Immunoblotting and densitometric quantification analyses illustrating OTUD1 protein expression in skin wound tissues from both control and T2DM mice (n = 3). (C) Representative immunohistochemical images and (D) quantitative analysis of showing OTUD1-positive cells (brown) in the skin wound tissues of mice. Black arrowheads indicate positive OTUD1 signals (Scale bar = 50 μm; n = 7). (E) Immunoblot and quantitative analysis of OTUD1 protein expression in HUVECs, HaCaT, HDFa, and MPM cells (n = 4). (F) Representative immunofluorescence images displaying the colocalization of CD31 (red) and OTUD1 (green) in mouse skin wound tissues, with white arrowheads showing OTUD1 and CD31 colocalization sites. Tissues were counterstained with DAPI (blue; Scale bar = 50 μm). (G) Immunofluorescence staining and (H) quantitative analysis of OTUD1-positive cells (red) in both control and HG + PA-treated HUVECs for 4 h, counterstained with DAPI (blue; Scale bar = 50 μm). (I) Time-course study of OTUD1 expression in response to HG + PA in HUVECs, including immunoblot analysis and quantitative measurement (n = 3). Data are shown as mean ± SEM. Statistical analyses were performed using a two-tailed unpaired Student's t -test (A, B, D), Welch’s t test (H), and one-way ANOVA analysis followed by Bonferroni post-hoc test (E, I). HG + PA indicates treatment with 50 mM HG and 300 μM PA, unless specified otherwise. Abbreviations: Ctrl, control; T2DM, type 2 diabetes mellitus; OTU, ovarian tumor protease; HUVECs, human umbilical vein endothelial cells; HaCaT, human keratinocytes; HDFa, human dermal fibroblasts-adult; MPMs, mouse primary peritoneal macrophages; DAPI, 4ʹ,6-diamidino-2-phenylindole; HG + PA, high glucose plus palmitic acid; and OTUD1, ovarian tumor deubiquitinase 1.

Journal: Journal of Advanced Research

Article Title: OTUD1 delays wound healing by regulating endothelial function and angiogenesis in diabetic mice

doi: 10.1016/j.jare.2025.04.038

Figure Lengend Snippet: Endothelial OTUD1 is significantly upregulated in diabetic wound tissues. (A) Real-time qPCR analysis for mRNA levels of OTU subfamily members in the skin wound tissues from control and T2DM mice (n = 7). (B) Immunoblotting and densitometric quantification analyses illustrating OTUD1 protein expression in skin wound tissues from both control and T2DM mice (n = 3). (C) Representative immunohistochemical images and (D) quantitative analysis of showing OTUD1-positive cells (brown) in the skin wound tissues of mice. Black arrowheads indicate positive OTUD1 signals (Scale bar = 50 μm; n = 7). (E) Immunoblot and quantitative analysis of OTUD1 protein expression in HUVECs, HaCaT, HDFa, and MPM cells (n = 4). (F) Representative immunofluorescence images displaying the colocalization of CD31 (red) and OTUD1 (green) in mouse skin wound tissues, with white arrowheads showing OTUD1 and CD31 colocalization sites. Tissues were counterstained with DAPI (blue; Scale bar = 50 μm). (G) Immunofluorescence staining and (H) quantitative analysis of OTUD1-positive cells (red) in both control and HG + PA-treated HUVECs for 4 h, counterstained with DAPI (blue; Scale bar = 50 μm). (I) Time-course study of OTUD1 expression in response to HG + PA in HUVECs, including immunoblot analysis and quantitative measurement (n = 3). Data are shown as mean ± SEM. Statistical analyses were performed using a two-tailed unpaired Student's t -test (A, B, D), Welch’s t test (H), and one-way ANOVA analysis followed by Bonferroni post-hoc test (E, I). HG + PA indicates treatment with 50 mM HG and 300 μM PA, unless specified otherwise. Abbreviations: Ctrl, control; T2DM, type 2 diabetes mellitus; OTU, ovarian tumor protease; HUVECs, human umbilical vein endothelial cells; HaCaT, human keratinocytes; HDFa, human dermal fibroblasts-adult; MPMs, mouse primary peritoneal macrophages; DAPI, 4ʹ,6-diamidino-2-phenylindole; HG + PA, high glucose plus palmitic acid; and OTUD1, ovarian tumor deubiquitinase 1.

Article Snippet: After one hour of blocking with rabbit serum (G1209, Servicebio), primary antibodies against CD31 (AF3628, R&D Systems, Minnesota, USA) were incubated for the whole night at 4 °C.

Techniques: Control, Western Blot, Expressing, Immunohistochemical staining, Immunofluorescence, Staining, Two Tailed Test

OTUD1 deficiency rescues impaired wound healing by enhancing angiogenesis and fibrosis in T2DM mice. (A) Schematic diagram illustrating the animal experiment procedure. The mice (B) FBG levels and (C) body weight were recorded from weeks 9 to 16 (n = 7). * P < 0.05 vs WT-Sham; ** P < 0.01 vs WT-Sham; *** P < 0.001 vs WT-Sham; ns, no significance. ns (green) indicates that there is no statistical significance between OTUD1 −/− -T2DM and WT-T2DM. (D) Representative wound images and (E) wound closure rates are shown (n = 5). *** P < 0.001 vs WT-Sham; ## P < 0.01 vs WT-T2DM; ns, no significance. (F) H&E staining demonstrated regenerated skin at day 12 across different groups. Scale bar = 50 μm. (G) Quantitative assessments of epidermis thickness in mice (n = 7). (H) Masson's trichrome staining and (I) quantitative analysis of collagen deposition in skin wound tissues at day 12 (Scale bar = 50 μm; n = 7). (J) Representative images and (K) quantification of CD31-positive (brown) neovascularization via immunohistochemical staining at days 3, 7, and 12 (Scale bar = 50 μm; n = 7). Black arrows indicate skin neovascularization. (L-O) Immunoblotting and quantification of OTUD1, VEGFR2, p-eNOS, and eNOS in wound tissue lysates from Sham or T2DM mice with WT or OTUD1 knockout, normalized to GAPDH (n = 4). Data are displayed as mean ± SEM. Statistical analyses were performed using two-way ANOVA analysis followed by Bonferroni post-hoc test (B, C, E) and one-way ANOVA analysis followed by Bonferroni post-hoc test (G, I, K, M-O). Abbreviations: WT, wild-type; OTUD −/− , OTUD1-knockout; HFD, high-fat diet; STZ, streptozotocin; FBG, fasting blood glucose; eNOS, endothelial nitric oxide synthase.

Journal: Journal of Advanced Research

Article Title: OTUD1 delays wound healing by regulating endothelial function and angiogenesis in diabetic mice

doi: 10.1016/j.jare.2025.04.038

Figure Lengend Snippet: OTUD1 deficiency rescues impaired wound healing by enhancing angiogenesis and fibrosis in T2DM mice. (A) Schematic diagram illustrating the animal experiment procedure. The mice (B) FBG levels and (C) body weight were recorded from weeks 9 to 16 (n = 7). * P < 0.05 vs WT-Sham; ** P < 0.01 vs WT-Sham; *** P < 0.001 vs WT-Sham; ns, no significance. ns (green) indicates that there is no statistical significance between OTUD1 −/− -T2DM and WT-T2DM. (D) Representative wound images and (E) wound closure rates are shown (n = 5). *** P < 0.001 vs WT-Sham; ## P < 0.01 vs WT-T2DM; ns, no significance. (F) H&E staining demonstrated regenerated skin at day 12 across different groups. Scale bar = 50 μm. (G) Quantitative assessments of epidermis thickness in mice (n = 7). (H) Masson's trichrome staining and (I) quantitative analysis of collagen deposition in skin wound tissues at day 12 (Scale bar = 50 μm; n = 7). (J) Representative images and (K) quantification of CD31-positive (brown) neovascularization via immunohistochemical staining at days 3, 7, and 12 (Scale bar = 50 μm; n = 7). Black arrows indicate skin neovascularization. (L-O) Immunoblotting and quantification of OTUD1, VEGFR2, p-eNOS, and eNOS in wound tissue lysates from Sham or T2DM mice with WT or OTUD1 knockout, normalized to GAPDH (n = 4). Data are displayed as mean ± SEM. Statistical analyses were performed using two-way ANOVA analysis followed by Bonferroni post-hoc test (B, C, E) and one-way ANOVA analysis followed by Bonferroni post-hoc test (G, I, K, M-O). Abbreviations: WT, wild-type; OTUD −/− , OTUD1-knockout; HFD, high-fat diet; STZ, streptozotocin; FBG, fasting blood glucose; eNOS, endothelial nitric oxide synthase.

Article Snippet: After one hour of blocking with rabbit serum (G1209, Servicebio), primary antibodies against CD31 (AF3628, R&D Systems, Minnesota, USA) were incubated for the whole night at 4 °C.

Techniques: Staining, Immunohistochemical staining, Western Blot, Knock-Out

Pharmacological inhibition of β-catenin reverses OTUD1 deletion-mediated recovery of delayed wound healing in db/db mice. (A) Schematic of the protocol for establishing the OTUD1 deletion mouse model in db/m or db/db mice. The mice (B) FBG levels and (C) body weight of the indicated mice at weeks 10, 12, 14, 16, 18, 20, 22, and 24 (n = 7). *** P < 0.001 vs db/m -AAV-shNC. ns (green) indicates that there is no statistical significance between db/db -AAV-shNC and db/db -AAV-shOTUD1. ns (purple) indicates that there is no statistical significance between db/db -AAV-shOTUD1 and db/db -AAV-shOTUD1-MSAB. (D) Skin wound healing images and (E) statistical analysis of wound closure rate (n = 5). ** P < 0.01 vs db/m -AAV-shNC; *** P < 0.001 vs db/m -AAV-shNC; ## P < 0.01 vs db/db -AAV-shNC; ### P < 0.001 vs db/db -AAV-shNC; && P < 0.01 vs db/db -AAV-shOTUD1; ns, no significance. (F) H&E staining images of skin wound tissues. Scale bar = 50 μm. (G) Representative Masson’s trichrome staining in skin wound tissues. Scale bar = 50 μm. (H) CD31 immunohistochemical staining of neovascularization in skin wound tissues on days 3, 7, and 12 (Scale bar = 50 μm). The black arrows denote skin neovascularization. (I) Representative immunoblotting and (J-M) quantitative analysis of OTUD1, VEGFR2, Nuc-β-catenin, p-eNOS, and eNOS protein levels in skin wound tissues from different groups (n = 4). Data are shown as mean ± SEM. Statistical analyses were performed using two-way ANOVA analysis followed by Bonferroni post-hoc test (B, C, E) and one-way ANOVA analysis followed by Bonferroni post-hoc test (J-M). Abbreviations: MSAB, ethionine sulfoxide β-methyl ester; AAV2/BI30-shOTUD1, adeno-associated virus serotype 2/BI30 carrying shOTUD1 under the CMV promoter.

Journal: Journal of Advanced Research

Article Title: OTUD1 delays wound healing by regulating endothelial function and angiogenesis in diabetic mice

doi: 10.1016/j.jare.2025.04.038

Figure Lengend Snippet: Pharmacological inhibition of β-catenin reverses OTUD1 deletion-mediated recovery of delayed wound healing in db/db mice. (A) Schematic of the protocol for establishing the OTUD1 deletion mouse model in db/m or db/db mice. The mice (B) FBG levels and (C) body weight of the indicated mice at weeks 10, 12, 14, 16, 18, 20, 22, and 24 (n = 7). *** P < 0.001 vs db/m -AAV-shNC. ns (green) indicates that there is no statistical significance between db/db -AAV-shNC and db/db -AAV-shOTUD1. ns (purple) indicates that there is no statistical significance between db/db -AAV-shOTUD1 and db/db -AAV-shOTUD1-MSAB. (D) Skin wound healing images and (E) statistical analysis of wound closure rate (n = 5). ** P < 0.01 vs db/m -AAV-shNC; *** P < 0.001 vs db/m -AAV-shNC; ## P < 0.01 vs db/db -AAV-shNC; ### P < 0.001 vs db/db -AAV-shNC; && P < 0.01 vs db/db -AAV-shOTUD1; ns, no significance. (F) H&E staining images of skin wound tissues. Scale bar = 50 μm. (G) Representative Masson’s trichrome staining in skin wound tissues. Scale bar = 50 μm. (H) CD31 immunohistochemical staining of neovascularization in skin wound tissues on days 3, 7, and 12 (Scale bar = 50 μm). The black arrows denote skin neovascularization. (I) Representative immunoblotting and (J-M) quantitative analysis of OTUD1, VEGFR2, Nuc-β-catenin, p-eNOS, and eNOS protein levels in skin wound tissues from different groups (n = 4). Data are shown as mean ± SEM. Statistical analyses were performed using two-way ANOVA analysis followed by Bonferroni post-hoc test (B, C, E) and one-way ANOVA analysis followed by Bonferroni post-hoc test (J-M). Abbreviations: MSAB, ethionine sulfoxide β-methyl ester; AAV2/BI30-shOTUD1, adeno-associated virus serotype 2/BI30 carrying shOTUD1 under the CMV promoter.

Article Snippet: After one hour of blocking with rabbit serum (G1209, Servicebio), primary antibodies against CD31 (AF3628, R&D Systems, Minnesota, USA) were incubated for the whole night at 4 °C.

Techniques: Inhibition, Staining, Immunohistochemical staining, Western Blot, Virus